Compare moats
Up to three covered companies, band by band. Every call is a curated editorial judgment, never a disclosed figure — and every band carries its cited basis.
| MaxLinear | ASMPT | Axcelis Technologies | |
|---|---|---|---|
| Moat rating | none MaxLinear’s FY2025 10-K does not show a durable advantage. Its income statement reports revenue of $693,263 thousand in 2023, $360,528 thousand in 2024 and $467,641 thousand in 2025, with operating losses of $38,221 thousand, $223,352 thousand and $126,890 thousand. The risk factors say “Increased competition has resulted in price pressure, decreased demand, reduced revenue and profitability, and loss of market share”; the business section says competitors include “companies with much longer operating histories, greater name recognition, and substantially greater financial, technical and operational resources”; and because its products “often are building block semiconductors” it also faces integrated-circuit makers, “some of which may be existing customers or platform partners”. Two customers were 28% of 2025 net revenue and the ten largest 65%, and “substantially all of our sales to date have been made on a purchase order basis”. Gross profit held up - $385,663 thousand, $194,782 thousand and $265,814 thousand for 2023 to 2025 - and the AI optical ramp has lifted 2026 results, but a revenue base that nearly halved in one year and three straight years of operating losses do not evidence a moat. | narrow ASMPT has a real but contested position in thermo-compression bonding (TCB), and its returns were thin until 2026. On the durable side, TrendForce (2025-12-12, citing The Elec) reports that SK hynix 'is using about fifty sets of TC bonders for HBM4 production, with roughly half supplied by ASMPT'. It adds that Hanmi had been SK hynix's exclusive TC bonder supplier for HBM 'until last year, when ASMPT joined the supply chain toward year-end'. ASMPT's FY2025 results announcement reports TCB revenue growth of about 146% and calls the company the 'Process-Of-Record' in chip-to-substrate bonding, which is its own claim. On the limiting side, the market is shared. TrendForce (2026-06-09, citing ET News) reports a 44.2 billion won SK hynix TC bonder order to Hanmi, and Kulicke & Soffa's FY2025 10-K lists ASM Pacific Technology among eight major equipment competitors. Returns were modest: the FY2025 announcement shows a continuing-operations adjusted gross margin of 38.3%, down 172 bps, and an adjusted SEMI segment profit margin of 8.4%. The 2026 interim results show a recovery, with SEMI's adjusted segment margin at 18.1% for 1H 2026. A contested technology lead with cyclical and recently thin returns supports a narrow moat, not a wide one. | narrow Axcelis's FY2025 10-K describes a protected but contested position. On the durable side, it says 'Axcelis and Applied Materials are the only ion implant system manufacturers with a full range of implant products'. About 3,400 Axcelis products are in use in 27 countries, and they feed an aftermarket business (CS&I) that earned $268.0 million, or 31.9% of 2025 revenue. The company holds 169 active U.S. patents and 356 active patents granted in other countries. On the limiting side, the risk factors say the ion implant segment 'includes one company with substantially greater financial, engineering, manufacturing, marketing and customer service and support resources', as well as 'several smaller companies that could provide innovative systems'. U.S. export controls 'exacerbate the risk that Chinese customers will change suppliers to non-U.S. vendors', while Kingstone Semiconductor and CETC 'continue to develop ion implanters for the Chinese domestic market'. 'None of our customers have entered into a long-term agreement requiring it to purchase our products.' Revenue fell to $839.0 million in 2025 from $1,017.9 million in 2024. A full-line position with a large installed base, against a better-resourced rival and new Chinese entrants, is a narrow moat. |
| Moat type | none No single source of advantage in the 10-K is strong enough to name. MaxLinear has “over one thousand issued patents” and says consideration under intellectual property sale agreements “has previously been and is currently expected in the future be material”, but the same filing describes its products as building blocks that larger vendors can integrate, says some optical-interconnect customers are “module makers who are vertically integrated, where we compete with internally supplied components”, and claims only that “We believe that we compete favorably” on factors from product performance to price. Its RF-CMOS integration know-how is real, but nothing in the filing shows customers locked in or rivals unable to match it. | intangibles ip The advantage sits in bonding process technology rather than in customer lock-in. The FY2025 results announcement credits chip-to-wafer TCB orders to an 'ultrafine pitch TCB solution equipped with proprietary plasma AOR technology', and says its HBM4 12H TCB solutions 'were the first to secure orders from multiple players'. TrendForce (2026-01-28, citing EE Times China) says ASMPT holds TCB and hybrid bonding capability, 'which the industry widely regards as the second most important technologies after lithography'. Kulicke & Soffa's FY2025 10-K says assembly equipment competes on 'price, speed/throughput, production yield, process control, delivery time, innovation, quality and customer support', which rewards technology. Switching costs are the weaker candidate: TrendForce (2025-12-12) shows SK hynix sourcing HBM4 TC bonders from both ASMPT and Hanmi. | intangibles ip The FY2025 10-K grounds the advantage in owned implant technology rather than contractual lock-in. Its Purion implanters share 'a common platform which enables a unique combination of implant purity, precision, and productivity', and its high energy systems use 'production-proven RF Linac high energy, spot beam technology'. System assembly and testing stays in-house 'due to the high degree of expertise and intellectual property associated with the process and design'. The company holds 169 active U.S. and 356 foreign patents, though it says it is not 'substantially dependent on any single patent or any group of patents'. The installed base supports aftermarket revenue but does not lock customers in: the risk factors say customers often train 'their own staff to maintain and service' equipment and buy parts that are not patent-protected from third parties. Switching costs are therefore the weaker candidate. |
| Leadership | fast follower In its fastest-growing line MaxLinear is a second source. Deep Fundamental’s September 27, 2024 deep dive (https://deepfundamental.substack.com/p/deep-dive-optical-module-market) says “Marvell ($MRVL) and Broadcom ($AVGO) are two major suppliers of DSPs, with Marvell holding the top position in the market”, that “Coherent also sources heavily from Marvell, with Broadcom/ Maxlinear potentially serving as second supplier with 20-30% share”, and that MaxLinear offers “DSPs at about half the price of Marvell's if it can achieve a meaningful mass production volume of at least 100K units per month”. Keystone has since reached volume - management said on the Q2 2026 call that it “continues to ramp into high volume production at major hyperscale customers across U.S. and Asia” - but the 10-K names Broadcom, Qualcomm, Realtek, Skyworks, Credo, MediaTek, Marvell, MACOM, Texas Instruments, Analog Devices, Renesas, Microchip and Semtech as primary merchant competitors, and no third-party source found ranks MaxLinear first in any of its markets. | co leader In HBM TCB, TrendForce (2025-12-12, citing The Elec) reports that roughly half of the about fifty TC bonders SK hynix uses for HBM4 came from ASMPT, and that SK hynix ordered seven more ASMPT systems at about 4 billion won each. Hanmi remains a major supplier: TrendForce (2026-06-09, citing ET News and Hankyung) reports a new SK hynix order to Hanmi worth 44.2 billion won, believed to cover around 15 units. In logic, ASMPT calls itself the 'Process-Of-Record' for chip-to-substrate TCB, which is its own claim. In wire and die bonders, Kulicke & Soffa's FY2025 10-K names ASM Pacific Technology among its major equipment competitors. The only third-party supplier split found covers one customer, SK hynix, and no third-party share figure for TCB, wire bonders or SMT was found, so the band is co_leader rather than clear_leader. | fast follower The FY2025 10-K says 'In the market for ion implantation systems, we mainly compete against Applied Materials' and that the two 'are the only ion implant system manufacturers with a full range of implant products'. It claims Axcelis 'has been a market leader in high energy ion implanters for many years' and is 'a technology leader and supplier of choice' in power devices. But its risk factors say the implant segment includes 'one company with substantially greater' resources (unnamed there; Applied Materials is the main rival it names), and it lists 'Achieve market share leadership across all served markets' as a 2026 goal rather than a current fact. No third-party market-share source was fetched, so these are the company's own claims. Which of the two full-line suppliers has the larger overall share is not established by the sources read. Because the only basis for a shared lead is the company's own description, and that description treats share leadership as a goal not yet met, the band is held at fast_follower rather than co_leader. |
| Pricing power | moderate Mixed. Gross profit has stayed in proportion through the cycle - the 10-K’s income statement shows $265,814 thousand on revenue of $467,641 thousand in 2025 - and the Q2 2026 release (https://www.sec.gov/Archives/edgar/data/0001288469/000128846926000050/a06302026exhibit991.htm) reports GAAP gross margin of 57.8% against 56.5% a year earlier, guiding Q3 to 57.0%-60.0%. But the 10-K says “From time to time, we have reduced the average unit price of our products due to competitive pricing pressures, new product introductions by us or our competitors, and for other reasons, and we expect that we will have to do so again in the future”, that under some distributor agreements “we provide protection for reductions in selling prices of the distributors' inventory”, and in optical DSPs it entered as the lower-priced challenger. | moderate Margins are healthy for equipment but not exceptional, and they move with volume. The FY2025 results announcement reports SEMI's adjusted gross margin at 43.3% (down 240 bps) and SMT's gross margin at 32.4% (down 218 bps), with a group adjusted gross margin of 38.3%. The 2026 interim results report Q2 2026 adjusted gross margins of 46.5% for SEMI and 36.8% for SMT, and attribute both year-on-year increases largely to higher volume. TrendForce (2026-01-28, citing EE Times China) says SMT 'mainly serves traditional PCB assembly', while semiconductor packaging equipment, 'especially advanced packaging tools for AI chips', offers 'significantly higher pricing power and margins'. | moderate The FY2025 10-K reports gross margin of 44.9% in 2025 against 44.7% in 2024. That held steady while revenue fell from $1,017.9 million to $839.0 million, but its risk factors warn that 'if we must lower prices to remain competitive without commensurate cost of goods savings, our gross margin and profitability will be adversely affected'. They also say that if suppliers raise component costs, Axcelis 'may not be able to raise the price of our products to cover all or part of the increased cost'. On the Q2 2026 call (https://www.marketbeat.com/earnings/reports/2026-8-5-axcelis-technologies-inc-stock/), management reported a non-GAAP gross margin of 42.7% (the call states its income-statement measures are non-GAAP unless noted, so it is not directly comparable with the 10-K's GAAP figures), 'slightly below our outlook of 43%', citing CS&I mix and higher than anticipated services costs. |
| Summary | MaxLinear is a fabless designer of RF, analog and mixed-signal communications SoCs whose core skill, per its FY2025 10-K, is combining broadband RF and analog front ends with digital signal processing in standard CMOS. It sells into broadband access (cable, fiber PON and DSL gateways - approximately 44% of 2025 net revenue), home connectivity (Wi-Fi, MoCA, G.hn and Ethernet), wired and wireless infrastructure including optical data-center DSPs, and industrial and multi-market interface and power products. After a downturn that took revenue from $693,263 thousand in 2023 to $360,528 thousand in 2024, the AI optical ramp is turning it around: the Q2 2026 release reports revenue of $168,847 thousand, up 55% year over year, with the infrastructure business up 145% on the Keystone PAM4 DSP ramp for 800G, and management raised its 2026 optical data-center revenue outlook to $210 million-$230 million on the call. The moat question is whether that growth rests on anything durable. In optical DSPs MaxLinear entered as a lower-priced second source to Marvell; elsewhere it competes with Broadcom, Qualcomm, Realtek and MediaTek, which can integrate the functions it sells; customers are concentrated; and the 10-K still carries the Silicon Motion arbitration over its terminated merger, whose outcome it says it cannot predict. On this record MaxLinear is a technically capable challenger without a moat. | ASMPT makes back-end manufacturing equipment in two segments. Semiconductor Solutions (SEMI) sells die and wire bonders, thermo-compression and hybrid bonders, and photonics assembly tools. SMT Solutions sells surface-mount systems for circuit-board assembly. In FY2025, continuing-operations revenue was HK$13,736.2 million, up 10.0%. SEMI contributed HK$7,380.5 million and SMT HK$6,355.8 million. Advanced packaging revenue was US$532.1 million, up 30.2% and 30% of group revenue, with a significant contribution from TCB. The company estimates the TCB market at about US$760.0 million in 2025, rising to US$1.6 billion in 2028, and targets a 35 to 40 percent share. Business accelerated in 2026. Continuing revenue for 1H 2026 was HK$8,902.6 million, up 42.5% year on year, at a 41.1% gross margin. In July 2026 the company received bulk orders for more than 50 chip-to-substrate TCB tools from OSAT customers. In memory, the interim results say the timing of new TCB purchases 'remains dependent on HBM4 product rollout schedules'. The portfolio is being reshaped. The sale of the NEXX deposition business closed on 3 June 2026, and TrendForce (2026-05-05) reported Applied Materials as the buyer at a base value of US$120 million. On 21 January 2026, ASMPT began a strategic options assessment for SMT that includes a possible divestiture, joint venture, spin-off or listing. The verdict is a narrow moat: a credible TCB position in a market shared with Hanmi and others, attached to mainstream bonder and SMT businesses with ordinary margins. | Axcelis is an ion-implant specialist. The FY2025 10-K says implantation was 98.2% of 2025 revenue, sold as the Purion family of high energy, high current and medium current single-wafer implanters, the Ovation batch implanters, and aftermarket parts, upgrades and services. Its strongest ground is power devices. Axcelis calls itself 'a technology leader and supplier of choice in the implant-intensive power device segment', which made up 55% of the value of 2025 system shipments, and its Purion Power Series covers silicon carbide wafers. 2025 was a down year: revenue fell to $839.0 million from $1,017.9 million, systems backlog to $457.0 million from $645.8 million, and operating profit to $119.3 million from $210.8 million, while gross margin held at 44.9%. The 10-K names Applied Materials as the main rival and the only other full-range implant maker; other competitors include Sumitomo Heavy Industries Ion Technology, Nissin Ion Equipment, Advanced Ion Beam Technology and two Chinese developers. Among its 2026 goals the company lists 'Achieve market share leadership across all served markets', which it has not yet reached. On the Q2 2026 call (https://www.marketbeat.com/earnings/reports/2026-8-5-axcelis-technologies-inc-stock/), management said electric vehicles remain the number one driver of silicon carbide demand. It also said it expects its merger with Veeco, under which each Veeco share converts into 0.3575 Axcelis shares according to the 10-K, to close in the second half of 2026, pending approval in China. |
| Chain position | MaxLinear sells chips, much of it through Asian distributors, ODMs and module makers - products shipped to Asia were 82% of 2025 net revenue, including 49% to Hong Kong - that build cable modems, PON terminals, Wi-Fi gateways, base-station radios and optical transceivers for operators and hyperscale data centers. In the AI chain it sits beside the optical-module makers as a DSP supplier, competing with Marvell and Broadcom and, at vertically integrated module makers, with internally supplied components. | Back-end equipment supplier to IDMs, OSATs, memory makers and electronics assemblers. China was 41% of 2025 revenue and the top five customers about 16%, per the FY2025 results announcement. | A front-end wafer-fab equipment supplier to chipmakers, concentrated in Asia and in power devices. The FY2025 10-K says implanter shipments to Asian customers were 76.0% of 2025 system revenue, international sales 83.7% of total revenue, and the top ten customers 55.2% of net sales. It also says sales to Chinese customers are expected to remain significant under U.S. export-control licensing. |
| Products (share / barrier) |
|
|
|
| Long-horizon vote | +0.01 at weight 0.20 · swarm neutral Editorial prior, not backtested. | +0.13 at weight 0.20 · swarm bearish Editorial prior, not backtested. | +0.06 at weight 0.20 · swarm bearish Editorial prior, not backtested. |